InvestorsHub Logo
Followers 226
Posts 11070
Boards Moderated 0
Alias Born 11/21/2008

Re: Risk vs Reward post# 62339

Friday, 04/17/2009 12:25:53 AM

Friday, April 17, 2009 12:25:53 AM

Post# of 289427
now that it's past midnight I can post again - hit my limit for Thurs at 11:45pm, lol - I'll have to stop being so cheap and pay the whatever to post however much I want (which would present a new set of problems more than likely)

...but re nootropics, it encompasses a fairly wide-range of pyscho-stimulants, from herbs to amphetimines, to a range of 'racitams' (ie piracitam, which I have a bottle of actually) - but loosely speaking, my guess is other bev'g's have some nootropics in them (most likely some herbal variations), such as "Drank", but I don't see nootropics as being part of Dranks branding, and therefore their market. Don't know what Weber's plans are with the KOMA line of drinks, but from the language he's using in the PR, it sounds like he's getting closer to branding this as a health & anti-aging relaxation bev'g.

The classic nootropic compounds are very safe, clinically tested over decades, so you're right in terms of side effects. Some are all natural, some are not. Some are legal/OTC (over the counter), some are prescription only. But thats just semantics in terms of branding the product. What's interesting to me where Weber wants to take this...